These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24258712)

  • 1. Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.
    Shima H; Yamagata K; Aikawa Y; Shino M; Koseki H; Shimada H; Kitabayashi I
    Int J Hematol; 2014 Jan; 99(1):21-31. PubMed ID: 24258712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MOZ is critical for the development of MOZ/MLL fusion-induced leukemia through regulation of Hoxa9/Meis1 expression.
    Katsumoto T; Ogawara Y; Yamagata K; Aikawa Y; Goitsuka R; Nakamura T; Kitabayashi I
    Blood Adv; 2022 Oct; 6(19):5527-5537. PubMed ID: 35947126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.
    Ullah M; Pelletier N; Xiao L; Zhao SP; Wang K; Degerny C; Tahmasebi S; Cayrou C; Doyon Y; Goh SL; Champagne N; Côté J; Yang XJ
    Mol Cell Biol; 2008 Nov; 28(22):6828-43. PubMed ID: 18794358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF).
    Qin S; Jin L; Zhang J; Liu L; Ji P; Wu M; Wu J; Shi Y
    J Biol Chem; 2011 Oct; 286(42):36944-55. PubMed ID: 21880731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A MOZ-TIF2 leukemia mouse model displays KAT6-dependent H3K23 propionylation and overexpression of a set of active developmental genes.
    Smolko AE; Sullivan DW; Olsen SN; Kang H; Whedon SD; Baell JB; Cole PA; Armstrong SA; Kuroda MI
    Proc Natl Acad Sci U S A; 2024 Jun; 121(26):e2405905121. PubMed ID: 38889153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain.
    Poplawski A; Hu K; Lee W; Natesan S; Peng D; Carlson S; Shi X; Balaz S; Markley JL; Glass KC
    J Mol Biol; 2014 Apr; 426(8):1661-76. PubMed ID: 24333487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP.
    Deguchi K; Ayton PM; Carapeti M; Kutok JL; Snyder CS; Williams IR; Cross NC; Glass CK; Cleary ML; Gilliland DG
    Cancer Cell; 2003 Mar; 3(3):259-71. PubMed ID: 12676584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the MOZ-TIF2 oncoprotein in mice represses senescence.
    Largeot A; Perez-Campo FM; Marinopoulou E; Lie-a-Ling M; Kouskoff V; Lacaud G
    Exp Hematol; 2016 Apr; 44(4):231-7.e4. PubMed ID: 26854485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MOZ fusion proteins in acute myeloid leukaemia.
    Troke PJ; Kindle KB; Collins HM; Heery DM
    Biochem Soc Symp; 2006; (73):23-39. PubMed ID: 16626284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity.
    Laue K; Daujat S; Crump JG; Plaster N; Roehl HH; ; Kimmel CB; Schneider R; Hammerschmidt M
    Development; 2008 Jun; 135(11):1935-46. PubMed ID: 18469222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.
    Largeot A; Paggetti J; Broséus J; Aucagne R; Lagrange B; Martin RZ; Berthelet J; Quéré R; Lucchi G; Ducoroy P; Bastie JN; Delva L
    Biochim Biophys Acta; 2013 Dec; 1833(12):3054-3063. PubMed ID: 23994619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells.
    Paggetti J; Largeot A; Aucagne R; Jacquel A; Lagrange B; Yang XJ; Solary E; Bastie JN; Delva L
    Oncogene; 2010 Sep; 29(36):5019-31. PubMed ID: 20581860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2.
    Liang J; Prouty L; Williams BJ; Dayton MA; Blanchard KL
    Blood; 1998 Sep; 92(6):2118-22. PubMed ID: 9731070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2.
    Tam WF; Hähnel PS; Schüler A; Lee BH; Okabe R; Zhu N; Pante SV; Raffel G; Mercher T; Wernig G; Bockamp E; Sasca D; Kreft A; Robinson GW; Hennighausen L; Gilliland DG; Kindler T
    Cancer Res; 2013 Jan; 73(1):373-84. PubMed ID: 23149921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bivalent interaction of the PZP domain of BRPF1 with the nucleosome impacts chromatin dynamics and acetylation.
    Klein BJ; Muthurajan UM; Lalonde ME; Gibson MD; Andrews FH; Hepler M; Machida S; Yan K; Kurumizaka H; Poirier MG; Côté J; Luger K; Kutateladze TG
    Nucleic Acids Res; 2016 Jan; 44(1):472-84. PubMed ID: 26626149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2.
    Yin H; Glass J; Blanchard KL
    Mol Cancer; 2007 Aug; 6():51. PubMed ID: 17697320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function.
    Kindle KB; Troke PJ; Collins HM; Matsuda S; Bossi D; Bellodi C; Kalkhoven E; Salomoni P; Pelicci PG; Minucci S; Heery DM
    Mol Cell Biol; 2005 Feb; 25(3):988-1002. PubMed ID: 15657427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia.
    Carapeti M; Aguiar RC; Goldman JM; Cross NC
    Blood; 1998 May; 91(9):3127-33. PubMed ID: 9558366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial readout of unmodified H3R2 and acetylated H3K14 by the tandem PHD finger of MOZ reveals a regulatory mechanism for HOXA9 transcription.
    Qiu Y; Liu L; Zhao C; Han C; Li F; Zhang J; Wang Y; Li G; Mei Y; Wu M; Wu J; Shi Y
    Genes Dev; 2012 Jun; 26(12):1376-91. PubMed ID: 22713874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2.
    Aikawa Y; Katsumoto T; Zhang P; Shima H; Shino M; Terui K; Ito E; Ohno H; Stanley ER; Singh H; Tenen DG; Kitabayashi I
    Nat Med; 2010 May; 16(5):580-5, 1p following 585. PubMed ID: 20418886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.